WNT2 and pancreatic neoplasm: In pancreatic cancer, direct Wnt pathway activation by upregulation of Wnt family member 2 (WNT2) and Wnt family member 7A (WNT7A) has frequently been observed, resulting in poor clinical outcomes [17,18].